Apellis Pharmaceuticals Plans Important Conference Call Soon

Author: Logan Wright Updated: 02-14-2025 07:19 AM

Apellis Pharmaceuticals Conference Call Announcement

WALTHAM, Mass. — Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) is gearing up to host a significant conference call and webcast aimed at discussing its financial outcomes for the fourth quarter and the entire year of 2024. This event is scheduled for a Friday morning and will commence at 8:30 a.m. ET.

How to Participate in the Call

To ensure seamless access to the live call, participants are encouraged to pre-register. This can easily be done prior to the scheduled time.

For those who prefer digital access, an audio webcast will also be available, along with a presentation deck. Interested parties can find this information on the “Events and Presentations” section of Apellis' investor relations page. After the call, a recording of the webcast will remain accessible for 90 days, enabling thorough review.

About Apellis Pharmaceuticals

Apellis Pharmaceuticals is recognized as a pioneering biopharmaceutical firm dedicated to the transformative development of therapies for relentless diseases. The company’s innovative approaches have led to the introduction of the first new class of complement medicines in over a decade, boasting two approved products that specifically target C3. This includes a groundbreaking therapy aimed at geographic atrophy, a paramount cause of global blindness. The company is enthusiastic about continuing to explore the potential of C3 targeting in treating various challenging diseases.

Company Commitment and Future Endeavors

With a robust foundation in scientific excellence, Apellis is devoted to making a tangible impact on patient lives through innovative treatments. The company firmly believes in the untapped opportunities provided by complement medicine, particularly in addressing serious conditions that have minimal treatment options. As Apellis navigates through its future, stakeholders remain optimistic about the advancements in their pipeline and the ongoing commitment to addressing unmet medical needs.

Connect with Apellis Pharmaceuticals

For those wishing to learn more about Apellis' groundbreaking therapies and ongoing research initiatives, further information can be explored on their official website or through their social media channels like Twitter and LinkedIn. Engaging with the company via these platforms offers insights into their vision, research endeavors, and community interaction.

Frequently Asked Questions

What is the purpose of the conference call?

The conference call aims to discuss Apellis Pharmaceuticals' financial results for the fourth quarter and full year of 2024.

How can I access the conference call?

Interested participants can pre-register for the call by visiting the appropriate link provided by Apellis. There will also be a live audio webcast available.

What are the key therapies developed by Apellis?

Apellis has developed two notable therapies targeting C3, including one that addresses geographic atrophy, which is a major cause of blindness.

How long will the webcast replay be available?

The replay of the conference call webcast will be accessible for 90 days after the event.

How can I learn more about Apellis Pharmaceuticals?

More information can be found on the Apellis website and through their social media platforms such as Twitter and LinkedIn.

About The Author

Dedicated Author and financial expert Logan Wright here, 29 years old. After earning an economics degree, I spent a number of years working in different financial industries. My great passion is enabling everyone, from any background or experience level, to understand and be literate in financial matters.

My books and writings are centered on simplifying difficult financial ideas into doable, understandable guidance. Whether it's retirement planning, investing, or budgeting, I want to arm readers with the information they need to make wise financial choices and realize their financial objectives.

Apart from writing, I also frequently post to financial blogs and organize webinars and workshops targeted at enlightening participants about personal finance. Always, my strategy is to offer concise, doable advice that can truly improve people's lives.

Away from work, I like to read, travel, and sample new foods. My goal is to infuse everything I do with the balance that I think is essential to both financial and personal well-being. By my profession, I want to encourage and enable people to confidently and clearly take charge of their financial futures.

Contact Logan Wright privately here. Or send an email with ATTN: Logan Wright as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.